Year: 2023

BOSTON and LONDON, Dec. 11, 2023 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy® (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD). MLD is a rare, fatal genetic disorder caused by a mutation in the gene responsible for encoding the enzyme arylsulfatase A (ARSA) leading to neurological damage and developmental regression. In its most severe form, babies develop normally but in late infancy start to rapidly lose the ability to walk, talk and interact with the world around them. These children may require 24-hour care, and the majority pass away within five years of disease onset, creating an enormous burden on...

Figure 1Plan View of the Salvador Target, highlighting diamond drill hole locations, core assay results, and soil, rock and Trado® mineralization along 1.5 km, including undrilled trend which extends over 1 km in strike length.Figure 2Figure 2: Aerial 3D oblique view of the Salvador Target, highlighting diamond drill hole locations and 2PGE+Au assay results. Ni-Cu sulfide assays reported herein for drill holes MES01, MES02, MES03 and MES04. Salvador remains open along strike and at depth.Figure 3Figure 3: DD23MES03 strip log showing strong correlation of 2PGE+Au and Ni-Cu sulfide mineralization within the ultramafic sequence.  VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today reports assay results...

Mercury’s ARES-SARMercury’s ARES-SAR product is the first commercially available flight testing simulator for air-to-ground synthetic aperture radar (SAR) systems.ANDOVER, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, today introduced the first commercially available flight testing simulator for air-to-ground synthetic aperture radar (SAR) systems. The ARES-SAR product builds on more than 25 years of test and train technology from the Mercury Processing Platform to enable government and commercial organizations to save time and costs by reducing the need for actual flight testing through the simulation of realistic SAR scenarios on the ground. SAR systems have become an integral tool...

James RayPresident and Chief Executive OfficerNEW ALBANY, Ohio, Dec. 11, 2023 (GLOBE NEWSWIRE) — Commercial Vehicle Group (“CVG” or the “Company”) (NASDAQ: CVGI), a global leader in the design and manufacturing of electrical systems, vehicle components and accessories, plastic products and robotic assemblies, today announced that its Board of Directors has appointed James Ray as the Company’s next President and Chief Executive Officer. On December 20, 2023, he will replace Interim CEO Robert Griffin, who will continue in his role as Chairman of the Board of Directors for CVG.The appointment of Mr. Ray follows an extensive, global search process led by international, executive search firm Heidrick & Struggles. The Board thanked Mr. Griffin for leading the Company during the search for the permanent President...

Miami, FL, Dec. 11, 2023 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared a quarterly dividend of $0.09 per share, or $0.36 per share on an annualized basis, for the fourth quarter of 2023. The dividend will be paid on January 31, 2024 to shareholders of record as of the close of business on December 29, 2023. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural...

Completed enrollment of the LEAD Phase 1/2 clinical trial of LX1001 for the treatment of APOE4-associated Alzheimer’s disease Received clearance of LX2006 Clinical Trial Application (CTA) in Canada for the treatment of FA cardiomyopathy; activated first clinical trial site outside of the United States Presented additional preclinical data on LX2020 for the treatment of PKP2-ACM at the 2023 American Heart Association Scientific Sessions Completed initial public offering (IPO) of common stock in November 2023, raising $111.5 million in gross proceeds and supporting operational runway into Q4 2025 NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s...

VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce that Solaris and OMF Fund IV SPV D LLC and OMF Fund IV SPV E LLC, entities managed by Orion Mine Finance Management LP (collectively, “Orion”), have entered into definitive agreements with respect to the previously announced financing package of US$80 million for the advancement of the Warintza Project (the “Project”) in Ecuador, comprised of a US$60 million senior secured debt facility (the “Senior Loan”), an offtake with a buyback provision (the “Offtake”), a subscription for US$10 million in equity and a commitment for US$10 million in additional equity financing. Highlights4-year term for the Senior Loan No hedging conditions Buyback provision for Offtake...

BEIJING, Dec. 11, 2023 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), a leading new energy vehicle manufacturer and one of the premium imported cars and used cars platform in China, today announced that it has established its AI Automotive Research Institute, with senior VP Mr. Lei Gu appointed as the dean, to facilitate the formation and integration of the company’s development strategy for artificial intelligence applications. Kaixin is also actively seeking to partner with leading AI companies to jointly create intelligent, safe and efficient automobile travel products and services. Mr. Lei Gu has served as senior expert with Ford Motor Company, dean of Chery Automobile Research Institute, chief engineer of BAIC Motor, and dean of Beijing Automotive Research Institute. He is a seasoned expert...

New data on Auvelity’s impact on quality of life, measured by the Q-LES-Q-SF, in patients who had received at least one prior treatment during their current depressive episode Data on Auvelity exploring reduction of depressive symptoms regardless of a patient’s interest-activity symptom severity NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced new data that treatment with Auvelity® (dextromethorphan-bupropion) was associated with improvement in quality of life outcomes in broad populations of depression patients in the EVOLVE open-label trial in major depressive disorder (MDD). These new data were presented at the American College of Neuropsychopharmacology...

ESC’s COO, Jeff Fallowfield appointed President of ESC Fallowfield is a 30-year industry veteran with proven leadership and strategic capabilities ESC to continue planned, strong growth path, leveraging best in class products and solutionsREGINA, Saskatchewan, Dec. 11, 2023 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today announced that Clare Colledge will be stepping down from her role as President of its wholly-owned subsidiary, ESC Corporate Services Ltd. (“ESC”), effective December 31, 2023. Concurrent with this departure, the Company is pleased to announce that Jeff Fallowfield has been appointed President of ESC, effective January 1, 2024. Jeff Fallowfield has over 30 years of leadership experience, including 8 years as the President, Corporate Development at LGM Financial Services...